Serge Roche

5.3k total citations
92 papers, 4.5k citations indexed

About

Serge Roche is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Serge Roche has authored 92 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 20 papers in Cell Biology and 17 papers in Oncology. Recurrent topics in Serge Roche's work include Protein Kinase Regulation and GTPase Signaling (33 papers), PI3K/AKT/mTOR signaling in cancer (17 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Serge Roche is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (33 papers), PI3K/AKT/mTOR signaling in cancer (17 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Serge Roche collaborates with scholars based in France, United States and Germany. Serge Roche's co-authors include Sara A. Courtneidge, Audrey Sirvent, Manfred Koegl, Christine Bénistant, Valérie Simon, Stefano Fumagalli, Patrick Raynal, Cédric Leroy, Richard Magous and H Chapuis and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Serge Roche

88 papers receiving 4.4k citations

Peers

Countries citing papers authored by Serge Roche

Since Specialization

Citations

This map shows the geographic impact of Serge Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Roche more than expected).

Fields of papers citing papers by Serge Roche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serge Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Roche. The network helps show where Serge Roche may publish in the future.

Co-authorship network of co-authors of Serge Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Serge Roche. A scholar is included among the top collaborators of Serge Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge Roche. Serge Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SLAP controls mTORC2 integrity via UBE3C-mediated non-degradative mLST8 ubiquitination to suppress colorectal tumorigenesis 2025 ·Cell Death and Differentiation ·(unknown), (unknown), (unknown), Cécile Naudin, (unknown), (unknown), (unknown), Valérie Simon, Yvan Boublik, (unknown), Serge Urbach, Serge Roche, Audrey Sirvent	0
2	Oncogenic Signalling of PEAK2 Pseudokinase in Colon Cancer 2022 ·Cancers ·(unknown), (unknown), (unknown), Clément Kerneur, Valérie Simon, Yvan Boublik, Débora Bonenfant, Bruno Robert, Pierre Martineau, Serge Roche	5
3	New functions of DDR1 collagen receptor in tumor dormancy, immune exclusion and therapeutic resistance 2022 ·Frontiers in Oncology ·Audrey Sirvent, (unknown), Evangelia S. Papadopoulou, (unknown), Serge Roche	8
4	SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-Kinase 2021 ·Cancers ·(unknown), (unknown), Yvan Boublik, Estelle Saland, (unknown), Christian Récher, Serge Urbach, Philippe Fort, Jean‐Emmanuel Sarry, Didier Fesquet, Serge Roche	6
5	Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis 2020 ·Cancers ·Audrey Sirvent, (unknown), (unknown), M. Lafitte, Serge Roche	17
6	DDR1 inhibition as a new therapeutic strategy for colorectal cancer 2018 ·Molecular & Cellular Oncology ·Audrey Sirvent, M. Lafitte, Serge Roche	17
7	Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells 2014 ·Molecular Oncology ·Muriel D. David, Cécile Naudin, (unknown), (unknown), Jack‐Michel Renoir, Vladimir Lazar, Philippe Dessen, Serge Roche, Jacques Bertoglio, Josiane Pierre	27
8	SLAP displays tumour suppressor functions in colorectal cancer via destabilization of the SRC substrate EPHA2 2014 ·Nature Communications ·Cécile Naudin, Audrey Sirvent, Cédric Leroy, Romain M. Larive, Valérie Simon, Julie Pannequin, Jean‐François Bourgaux, Josiane Pierre, Bruno Robert, Frédéric Hollande, Serge Roche	38
9	Progastrin a new pro-angiogenic factor in colorectal cancer 2014 ·Oncogene ·Souad Najib, Aline Kowalski‐Chauvel, Catherine Do, Serge Roche, (unknown), Catherine Seva	20
10	Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells 2011 ·Blood ·Romain Gioia, Cédric Leroy, Claire Drullion, Valérie Lagarde, Gabriel Étienne, Stéphanie Dulucq, Éric Lippert, Serge Roche, François‐Xavier Mahon, Jean‐Max Pasquet	75
11	Specific Oncogenic Activity of the Src-Family Tyrosine Kinase c-Yes in Colon Carcinoma Cells 2011 ·PLoS ONE ·(unknown), Aurélie Dumont, Audrey Sirvent, (unknown), (unknown), (unknown), Michel Jan, Catherine de Montrion, Francis Cogé, Stéphane Léonce, (unknown), Alain Bruno, Jean A. Boutin, Brian Lockhart, Serge Roche, Francisco Cruzalegui	33
12	Quantitative Phosphoproteomics Reveals a Cluster of Tyrosine Kinases That Mediates Src Invasive Activity in Advanced Colon Carcinoma Cells 2009 ·Cancer Research ·Cédric Leroy, (unknown), Audrey Sirvent, Valérie Simon, Serge Urbach, Joël Poncet, Bruno Robert, Patrick Jouin, Serge Roche	93
13	Alternative Splicing Modulates Autoinhibition and SH3 Accessibility in the Src Kinase Fyn 2009 ·Molecular and Cellular Biology ·(unknown), Maria Paola Paronetto, Sandrine Opi, (unknown), Stéphane Audebert, Vincent Feuillet, Georges Bismuth, Serge Roche, Stefan T. Arold, Claudio Sette, Yves Collette	28
14	A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling 2009 ·Cellular Signalling ·José Manuel García-Martínez, Annarica Calcabrini, Lorena González, (unknown), M. Teresa Agulló-Ortuño, Valérie Simon, (unknown), (unknown), Serge Roche, Jorge Martı́n-Pérez	36
15	Evidence that Resistance to Nilotinib May Be Due to BCR-ABL, Pgp, or Src Kinase Overexpression 2008 ·Cancer Research ·François‐Xavier Mahon, Sandrine Hayette, Valérie Lagarde, Françis Belloc, Béatrice Turcq, Franck E. Nicolini, Coralie Bélanger, Paul W. Manley, Cédric Leroy, Gabriel Étienne, Serge Roche, Jean‐Max Pasquet	174
16	The Adaptor Protein Tom1L1 Is a Negative Regulator of Src Mitogenic Signaling Induced by Growth Factors 2006 ·Molecular and Cellular Biology ·Mélanie Franco, (unknown), Valérie Simon, (unknown), (unknown), Serge Roche	34
17	Cyclin E and cyclin A are likely targets of Src for PDGF‐induced DNA synthesis in fibroblasts 2002 ·FEBS Letters ·(unknown), Gaël Manès, Serge Roche	13
18	Src-like adaptor protein (Slap) is a negative regulator of mitogenesis 1998 ·Current Biology ·Serge Roche, Gema Alonso, Andrius Kazlauskas, Vishva M. Dixit, Sara A. Courtneidge, Akhilesh Pandey	59
19	The Src SH3 Domain Is Required for DNA Synthesis Induced by Platelet-derived Growth Factor and Epidermal Growth Factor 1996 ·Journal of Biological Chemistry ·Thorsten Erpel, Gema Alonso, Serge Roche, Sara A. Courtneidge	55
20	Biphasic kinetics of inositol 1,4,5‐trisphosphate accumulation, in gastrin‐stimulated parietal cells Effects of pertussis toxin and extracellular calcium 1991 ·FEBS Letters ·Serge Roche, (unknown), Jean-Pierre Balì, Richard Magous	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact